Nakamura S, Muro H, Suzuki S, Sakaguchi T, Konno H, Baba S, Syed A S
Second Department of Surgery, Hamamatsu University School of Medicine, Handa-cho, Hamamatsu-city, Japan.
Hepatology. 1997 Aug;26(2):407-15. doi: 10.1002/hep.510260222.
To examine the phenotype of the sinusoidal endothelial cells (SECs) surrounding tumor cells and the process of capillarization in hepatocellular carcinoma (HCC), 51 primary HCCs, 4 adrenal metastases, and 3 portal tumor thrombi were immunohistochemically stained with monoclonal antibodies (MAbs) for CD4, CD14 (lipopolysaccharide-binding protein complex receptors), and CD32 (Fc gamma receptor II), which are specifically found on the SECs in normal liver, but not on ordinary vascular endothelial cells (ECs). Immunostaining was also performed for CD36 (thrombospondin receptors), EN4 antigen (Ag) (a pan-vascular endothelial cell Ag), PAL-E Ag (a venous and capillary EC Ag), factor VIII-related Ag (FVIIIRAg), and laminin. MAb 25F9, which identifies macrophages, was simultaneously used with the other MAbs to distinguish macrophages from SECs in HCCs (HCC SECs). CD4, CD14, and/or CD32 were found on HCC SECs only in 12 well-differentiated primary HCCs showing a thin trabecular or pseudoglandular tumor cell arrangement. These 12 tumors were smaller than those without CD4-, CD14-, and/or CD32-positive SECs (P < .05). Among them, 7, 5, and 11 tumors were negative or only partially positive for laminin, PAL-E Ag, and FVIIIRAg, respectively. Staining for laminin and PAL-E Ag showed an inverse relationship to the expression of CD4, CD14, and CD32 on HCC SECs and the tumor differentiation. In conclusion, the phenotypes of the SECs in early and well-differentiated HCC are thought to be similar to those of the SECs in normal liver. With progressing tumor dedifferentiation the HCC SECs lose the phenotypes peculiar to liver SECs and acquire the characteristics of capillary ECs, though both types of phenotypical change occur independently of each other.
为研究肿瘤细胞周围肝血窦内皮细胞(SEC)的表型及肝细胞癌(HCC)中毛细血管化过程,采用单克隆抗体(MAb)对51例原发性HCC、4例肾上腺转移瘤及3例门静脉瘤栓进行免疫组织化学染色,这些抗体针对CD4、CD14(脂多糖结合蛋白复合物受体)和CD32(Fcγ受体II),它们在正常肝脏的SEC上特异性表达,而在普通血管内皮细胞(EC)上不表达。同时对CD36(血小板反应蛋白受体)、EN4抗原(Ag)(一种泛血管内皮细胞Ag)、PAL-E Ag(一种静脉和毛细血管EC Ag)、因子VIII相关Ag(FVIIIRAg)和层粘连蛋白进行免疫染色。用于识别巨噬细胞的MAb 25F9与其他MAb同时使用,以区分HCC中的巨噬细胞与SEC(HCC SEC)。仅在12例高分化原发性HCC中发现HCC SEC上有CD4、CD14和/或CD32,这些肿瘤细胞呈细梁状或假腺管状排列。这12例肿瘤比无CD4、CD14和/或CD32阳性SEC的肿瘤小(P <.05)。其中,分别有7例、5例和11例肿瘤的层粘连蛋白、PAL-E Ag和FVIIIRAg呈阴性或仅部分阳性。层粘连蛋白和PAL-E Ag染色与HCC SEC上CD4、CD14和CD32的表达及肿瘤分化呈负相关。总之,早期高分化HCC中SEC的表型被认为与正常肝脏中SEC的表型相似。随着肿瘤去分化进展,HCC SEC失去肝脏SEC特有的表型并获得毛细血管EC的特征,尽管这两种表型变化相互独立发生。